Harbor Health Care ETF (MEDI)
$32.74
▼ -0.19 (-0.58%)
1-day change
$32.38 – $35.61
52-week range
Top 10 holdings weight59.70%
Effective number of positions13.1
Positions above 1%27
Net assets
$41.2M
Holdings
44
As of
July 31, 2026
MEDI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Sept. 30, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -3.45% | ▼ -3.45% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▼ -5.10% | ▼ -5.10% |
Volatility 1Y·
Volatility 3Y·
Max drawdown 3Y
·
Beta 3Y·
Sharpe 1Y*·
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Last month (Jul 2026)
+$0
Quarter ending Jul 2026
+$10.6M
Trailing 12 months
+$19.7M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 44 holdings · Category: EC
| Name | CUSIP | Value | % | Balance | Country |
|---|---|---|---|---|---|
| Eli Lilly & Co | 532457108 | $8.6M | 20.78 | 7,455 | US |
| Ascendis Pharma A/S | · | $5.6M | 13.61 | 22,993 | DK |
| Gilead Sciences Inc | 375558103 | $2.1M | 5.10 | 16,135 | US |
| Rhythm Pharmaceuticals Inc | 76243J105 | $1.7M | 4.02 | 16,680 | US |
| AbbVie Inc | 00287Y109 | $1.3M | 3.09 | 5,079 | US |
| Intuitive Surgical Inc | 46120E602 | $1.2M | 2.83 | 3,300 | US |
| Cencora Inc | 03073E105 | $1.1M | 2.75 | 3,634 | US |
| Revolution Medicines Inc | 76155X100 | $1.0M | 2.54 | 5,583 | US |
| Insmed Inc | 457669307 | $1.0M | 2.52 | 10,513 | US |
| Merck & Co Inc | 58933Y105 | $1.0M | 2.47 | 7,807 | US |
| Boston Scientific Corp | 101137107 | $989K | 2.40 | 21,166 | US |
| Natera Inc | 632307104 | $930K | 2.26 | 3,475 | US |
| Abivax SA | 00370M103 | $892K | 2.16 | 7,139 | FR |
| Insulet Corp | 45784P101 | $864K | 2.10 | 5,226 | US |
| Argenx SE | 04016X101 | $855K | 2.07 | 1,001 | NL |
| Vaxcyte Inc | 92243G108 | $849K | 2.06 | 15,695 | US |
| McKesson Corp | 58155Q103 | $834K | 2.02 | 974 | US |
| Legend Biotech Corp | 52490G102 | $787K | 1.91 | 42,415 | KY |
| Danaher Corp | 235851102 | $711K | 1.73 | 3,647 | US |
| Guardant Health Inc | 40131M109 | $636K | 1.54 | 3,925 | US |
| Novo Nordisk A/S | 670100205 | $602K | 1.46 | 12,780 | DK |
| IDEXX Laboratories Inc | 45168D104 | $578K | 1.40 | 1,034 | US |
| UnitedHealth Group Inc | 91324P102 | $573K | 1.39 | 1,382 | US |
| PTC Therapeutics Inc | 69366J200 | $538K | 1.31 | 7,913 | US |
| Vertex Pharmaceuticals Inc | 92532F100 | $502K | 1.22 | 1,053 | US |
| Alnylam Pharmaceuticals Inc | 02043Q107 | $499K | 1.21 | 2,430 | US |
| Thermo Fisher Scientific Inc | 883556102 | $480K | 1.16 | 835 | US |
| Adaptive Biotechnologies Corp | 00650F109 | $403K | 0.98 | 17,855 | US |
| Madrigal Pharmaceuticals Inc | 558868105 | $382K | 0.93 | 817 | US |
| Praxis Precision Medicines Inc | 74006W207 | $376K | 0.91 | 1,221 | US |
| Dexcom Inc | 252131107 | $332K | 0.81 | 3,979 | US |
| RadNet Inc | 750491102 | $328K | 0.80 | 5,146 | US |
| Penumbra Inc | 70975L107 | $317K | 0.77 | 987 | US |
| Relay Therapeutics Inc | 75943R102 | $264K | 0.64 | 14,039 | US |
| Oruka Therapeutics Inc | 687604108 | $246K | 0.60 | 2,546 | US |
| IRhythm Holdings Inc | 450056106 | $237K | 0.58 | 2,025 | US |
| Viatris Inc | 92556V106 | $236K | 0.57 | 13,424 | US |
| Newamsterdam Pharma Co NV | · | $213K | 0.52 | 7,656 | NL |
| Xenon Pharmaceuticals Inc | 98420N105 | $211K | 0.51 | 3,362 | CA |
| Indivior Pharmaceuticals Inc | 45579U109 | $206K | 0.50 | 5,144 | US |
| Axsome Therapeutics Inc | 05464T104 | $203K | 0.49 | 929 | US |
| Inventiva SACA | 46124U107 | $152K | 0.37 | 33,996 | FR |
| Sophia Genetics SA | · | $138K | 0.33 | 24,267 | CH |
| Ionis Pharmaceuticals Inc | 462222100 | $84K | 0.20 | 1,631 | US |
Sector breakdown
Dividends 3 payments
0.23%TTM yield
$0.08TTM payout / share
Annual
(est.)
| Ex-date | Amount / share |
|---|---|
| Dec. 19, 2025 | $0.0750 |
| Dec. 20, 2024 | $0.1350 |
| Dec. 21, 2023 | $0.4610 |
Institutional owners (13F) 12 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| LPL Financial LLC | $7,983,837 | 29.23% | 235,929 | Shares | June 30, 2026 |
| Pinnacle Financial Partners, Inc. | $7,332,354 | 26.84% | 216,677 | Shares | June 30, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $7,099,070 | 25.99% | 209,783 | Shares | June 30, 2026 |
| SYNOVUS FINANCIAL CORP | $1,257,945 | 4.60% | 44,036 | Shares | Sept. 30, 2025 |
| TRUIST FINANCIAL CORP | $925,152 | 3.39% | 27,339 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $743,736 | 2.72% | 21,978 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $708,846 | 2.59% | 20,947 | Shares | June 30, 2026 |
| GTS SECURITIES LLC | $611,320 | 2.24% | 18,065 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $378,568 | 1.39% | 11,187 | Shares | June 30, 2026 |
| Private Advisor Group, LLC | $253,800 | 0.93% | 7,500 | Shares | June 30, 2026 |
| PRIVATE TRUST CO NA | $12,521 | 0.05% | 370 | Shares | June 30, 2026 |
| Steward Partners Investment Advisory, LLC | $11,167 | 0.04% | 330 | Shares | June 30, 2026 |